neural interfaces conference Diskobolos (the discus thrower) with neural interface equipment
By the National Institutes of Health

Steering Committee
P. Hunter Peckham P. Hunter Peckham, PhD
Case Western University

Dr. Peckham is a biomedical engineer and is Chairman of the Steering Committee. He is the Donnell Institute Professor of Biomedical Engineering and Orthopaedics at Case Western Reserve University, Director of the Department of Veterans Affairs Functional  Electrical Stimulation Center, and Director of the Ohio Neuromodulation and Neurostimulation Biomedical Research and Commercialization Program, and Director of Orthopaedic Research at MetroHealth Medical Center. He has led the development of implantable neuroprostheses and their introduction through clinical trials into clinical use.





Warren M. Grill Warren M. Grill, PhD

Dr. Grill is an Associate Professor of Biomedical Engineering at Duke University. Dr. Grill's research involves design and testing of electrodes and stimulation techniques, the electrical properties of tissue and cells, and computational neuroscience with applications in restoration of the bladder function, treatment of movement disorders with deep brain stimulation, and multi-joint limb movement.





Jamie Henderson, MD
Stanford University

Jaimie Henderson received his B.A degree at Washington University, St. Louis, Biology in 1984, M.D. at Rush Medical College in 1988, Medical Education and Internship at Rush University Medical College, IL in 1988 and 1989 respectively, and completed his residency at St. Louis University Hospital, MO in 1995. Dr. Henderson received his Board Certification in Neurological Surgery at the American Board of Neurological Surgery in 2000. His clinical focus is in Neurological Surgery and Neurosurgery. Dr. Henderson received his administrative appointment at Stanford University Medicine as Director, Stereotactic and Functional Neurosurgery in 2004, where he is currently serving. He has Graduate and Fellowship Program Affiliations in Neurosurgery. Dr. Henderson conducted Clinical Trials in Safety and Efficacy Study of GAD Gene Transfer Therapy in Parkinson’s disease, (no longer recruiting.) His current research interests encompass several areas of stereotactic and functional neurosurgery, including frameless stereotactic approaches for therapy delivery to deep brain nuclei; deformable patient-specific atlases for targeting brain structures; cortical physiology and its relationship to normal and pathological movement; neural prostheses; and the development of novel neuromodulatory techniques for the treatment of movement disorders, pain, and other neurological diseases.





Robert Kirsch, Ph.D.,
Case Western University

Dr. Kirsch, Ph.D. is a Professor of Biomedical Engineering at Case Western Reserve University and Associate Director of the Department of Veterans Affairs Functional Electrical Stimulation Center of Excellence. His research focuses on the restoration of arm movements to individuals with complete paralysis of arm muscles due to spinal cord injury or other neurological disorders using functional electrical stimulation (FES), as well as on the mechanics and neural control of human movement. Current projects are focusing on (1) restoring shoulder and arm movements to individuals with cervical spinal cord injuries using implanted FES, (2) investigating new, high performance user command interfaces (such as intracortical brain computer interfaces) for these FES users, (3) developing sensor-based control algorithms for FES systems, and (4) developing new control algorithms for myoelectric (powered) prosthetic arms that can be implemented using an implanted MES recording system.

 

 

Zelma Kiss, M.D., Ph.D.,
University of Alberta at Calgary

Zelma HT Kiss MD PhD is an Associate Professor of Neurosurgery and Neuroscience at the University of Calgary, where she conducts basic and clinical research on the mechanisms of action of deep brain stimulation (DBS) and somatosensory restoration with neural prostheses. Her research is funded by the Canadian Institutes of Health Research, Alberta Heritage Foundation for Medical Research and the Parkinson Society Canada. Her clinical interests are in functional and stereotactic neurosurgery, including movement disorders, epilepsy, depression and various types of pain syndromes. She is Director of Neuromodulation for Alberta Health Services Calgary.

 

Kip Ludwig, PhD.,
NINDS, NIH

Dr. Kip Ludwig joined the National Institute for Neurological Disorders and Stroke as the Program Director for Neural Engineering in 2011. Dr. Ludwig received his Ph.D. in Biomedical Engineering at the University of Michigan, followed by post-doctoral work at the same institution. Dr. Ludwig's academic work focused on neural decoding algorithms for brain-computer interfaces (BCI), signal processing techniques to denoise neural recordings, and advance materials to improve the chronic stimulating and recording performance of microelectrodes. More recently Dr. Ludwig worked in industry as a research scientist, where he and his team conceived, developed and demonstrated the chronic efficacy of a next-generation neural stimulation electrode for reducing blood pressure in both pre-clinical and clinical trials. Through his industry work, he oversaw good laboratory practice (GLP) and non-GLP studies supporting both European and FDA Investigational Device Exemption (IDE) human trials, as well as participated in the protocol development and execution of those trials. Dr. Ludwig's interest is in all aspects of neural engineering, with special emphases on neuromodulation, BCI devices, and neural interface technology development.

 

 

Helen Mayberg, M.D.,
Emory University

Dr. Mayberg is Professor of Neurology and Psychiatry and the Dorothy C. Fuqua Chair in Psychiatric Neuroimaging and Therapeutics at the Emory University School of Medicine where she runs a multidisciplinary, translational depression research program. Studies focus on neural systems mediating mood and emotions in health and disease with a primary emphasis on major depression and its recovery. Experiments aim to identify imaging biomarkers and develop algorithms to discriminate patient subgroups, optimize treatment selection, and predict illness risk and relapse vulnerability, complementing ongoing testing and refinement of deep brain stimulation of the subcallosal cingulate (SCC) for treatment resistant depressed patients.

 

Joseph Pancrazio Joseph J. Pancrazio, PhD
George Mason University

Joseph J. Pancrazio earned a B.S. degree in Electrical Engineering from the University of Illinois, Urbana, in 1984, and M.S. and Ph.D. degrees in Biomedical Engineering from the University of Virginia (UVa), Charlottesville, in 1988 and 1990, respectively. His Ph.D. training focused on the ion channel electrophysiology using the patch clamp technique. After postdoctoral training in pharmacology in the Department of Anesthesiology at UVa as a recipient of a National Research Service Award, he received a joint appointment in the Departments of Anesthesiology and Biomedical Engineering as an assistant professor of research at the UVa in 1991. In 1997, he joined Georgetown University Department of Biochemistry and Molecular Biology as an Assistant Professor working at the US Naval Research Laboratory (NRL) in Washington, DC. In 1998, he joined the NRL as a Principal Investigator at the Center for Bio/Molecular Science and Engineering, becoming the Head of Code 6920, the Laboratory of Biomolecular Dynamics, in 2002. At the NRL, Dr. Pancrazio led an extramurally supported project including biologists and engineers for the development and demonstration of a biosensor system based cultured neuronal networks for environmental threat detection. He has authored over 80 peer-reviewed publications, several book chapters and review papers, and has two patents. Dr. Pancrazio joined the Repair and Plasticity Cluster of NIH in the National Institute of Neurological Disorders and Stroke (NINDS) in January of 2004, where he served as the Program Director for neural engineering and the neural prosthesis program. In October 2009, he joined the faculty in the Volgenau School of Information Technology and Engineering as Professor of Electrical and Computer Engineering and Director of the new Bioengineering Program. His research interests center on neural interface technologies, biosensors, and neuropharmacological assay development.





Krishna Shenoy, PhD
Stanford University

Prof. Shenoy heads the Neural Prosthetic Systems Lab (NPTL) at Stanford University where his group conducts neuroscience and neuroengineeringresearch to better understand how the brain controls movement, and to design medical systems to assist those with movement disabilities. His neuroscience (systems and cognitive neuroscience) research investigates the neural basis of movement preparation and generation using a combination of electrophysiological (single-electrode and chronic electrode-array recordings in rhesus monkeys), behavioral, computational and theoretical techniques. His neuroengineering (electrical, bio, and biomedical engineering) research investigates the design of high-performance neural prosthetic systems, which are also known as brain-computer interfaces (BCIs) and brain-machine interfaces (BMIs). These systems translate neural activity from the brain into control signals for prosthetic devices, which assist disabled patients by restoring lost function. This work includes statistical signal processing, machine learning, low-power circuits, and real-time system modeling and implementation. Education, awards and honors include: BS Electrical Engineering, UC Irvine, Summa Cum Laude, Prof. G.L. Shaw (1990); NSF Graduate Fellow (1990-1995); SM Electrical Engineering, MIT, Prof. C.G. Fonstad, Jr. (1992); Hertz Foundation Graduate Fellow (1992-1995); PhD Electrical Engineering, MIT, Prof. C.G. Fonstad, Jr. (1995); Hertz Foundation Doctoral Thesis Prize (1996); Postdoc, Neurobiology, Caltech, Prof. R.A. Andersen (1995-1998); Senior Postdoc, Neurobiology, Caltech, Prof. R.A. Andersen (1998-2001); Burroughs Wellcome Fund Career Award in the Biomedical Sciences (1999); Assistant Professor, Stanford University (2001-2008); Alfred P. Sloan Research Fellow (2002); Defense Science Research Council (DSRC/DARPA) Fellow (2003-2005); DSRC/DARPA Member (2005-2009); IEEE Senior Member, Engineering in Medicine and Biology Society (2006); McKnight Technological Innovations in Neurosciences Award (2007); Associate Professor (tenured), Stanford University (2008-); Program Co-Director/Co-PI, NSF Integrative Graduate Education and Research Traineeship (IGERT) interdisciplinary program entitled, “Emergent Functions of Neural Systems,” part of Stanford’s Center for Mind, Brain and Computation; Editorial board, Journal of Neurophysiology (2008-); Charles Lee Powell Faculty Scholar, School of Engineering, Stanford University (2008-2011); Co-Director (along with Co-Director Prof. Jaimie Henderson), Neural Prosthetics Translational Laboratory (NPTL), part of Stanford Institute for Neuro-Innovation and Translational Neuroscience (SINTN) and Stanford's Bio-X / NeuroVentures program (2009-); 2009 NIH Director's Pioneer Award (2009-2014).





James Weiland James Weiland, PhD
University of Southern California

Dr. Weiland is Associate Professor of Ophthalmology and Biomedical Engineering University of Southern California. Dr. Weiland's interests include retinal prostheses, neural prostheses, electrode technology, visual evoked responses and implantable electrical systems.





Richard A. Normann, PhD
University of Utah

Richard A. Normann, Ph.D. is a Distinguished Professor of Bioengineering and Ophthalmology at the University of Utah in Salt Lake City where he conducts research on sensory encoding and information processing by neural ensembles in the vertebrate central and peripheral nervous systems. He is the inventor of the Utah Electrode Array technologies and other high-electrode-count microelectrode arrays that can be used for basic and applied research in emerging field of neuroprosthetics. His current research interests are the cortically based restoration of vision in those with profound blindness, and peripheral nerve interventions for the restoration of stance and bladder control in those who have lost these functions. normann@utah.edu




 

  Presented by the National institutes of Health. Designed by FORM.